Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 4/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | TYR | P14679 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2257428 | 0.93 | LIPG (0.45) | LIPGTLR8MAPTCYP3A4TYR | |
| SCHEMBL2251371 | 0.93 | LIPG (0.45) | LIPGTLR8MAPTCYP3A4TYR | |
| SCHEMBL5750515 | 0.93 | LIPG (0.45) | LIPGTLR8MAPTCYP3A4TYR | |
| SCHEMBL1368599 | 0.89 | KDM4E (0.36) | CNR2 | |
| SCHEMBL1371874 | 0.88 | BCHE (0.36) | LIPGTLR8BCHE | |
| SCHEMBL9162717 | 0.84 | TSHR (0.35) | BCHEMAPTCYP3A4CYP2C9 | |
| SCHEMBL1975122 | 0.83 | LIPG (0.41) | LIPGTLR8 | |
| SCHEMBL2247387 | 0.81 | LIPG (0.44) | LIPGTLR8MAPT | |
| SCHEMBL2252287 | 0.81 | LIPG (0.44) | LIPGTLR8MAPT | |
| SCHEMBL5746577 | 0.81 | LIPG (0.44) | LIPGTLR8MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023038077-A1 | INKJET PRINTING METHOD | 日本化薬株式会社 | 2023-03-16 | — | — | WO | disclosed |
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| WO-2018158150-A1 | TREATMENT OF DEMENTIA WITH CANNABINOID AGONISTS | UNIVERSIDAD DEL PAÍS VASCO/EUSKAL HERRIKO UNIBERTSITATEA (ES) | 2018-09-07 | — | — | WO | disclosed |
| EP-2818462-B1 | CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMISCENT ELEMENT CONTAINING THESE AS COMPONENT | TOSOH CORP (JP) | 2017-11-08 | — | — | EP | disclosed |
| US-9624193-B2 | Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component | TOSOH CORPORATION (JP) | 2017-04-18 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
| US-9469662-B2 | Process for preparing optically active biophosphinylalkanes | BASF SE (DE) | 2016-10-18 | — | — | US | disclosed |
| EP-2746271-B1 | Phenyl-substituted 1, 3, 5-triazine compounds as intermediates for electroluminescent molecules | TOSOH CORP (JP) | 2016-08-17 | — | — | EP | disclosed |
| CN-105764885-A | Acid- and radical-generating agent and method for generating acid and radical | 和光纯药工业株式会社 | 2016-07-13 | — | — | CN | disclosed |
| US-20150329544-A1 | CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT | TOSOH CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| WO-2007012655-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE DIPHOSPHANES | BASF SE (DE) | 2007-02-01 | — | — | WO | disclosed |
| EP-1411912-A1 | TREATMENT OF CHRONIC PAIN WITH 3-ARYLOXY-3-PHENYLPROPANAMINES | PHARMACIA & UPJOHN COMPANY (US) | 2004-04-28 | — | — | EP | disclosed |
| EP-1411934-A1 | TREATMENT OF CHRONIC PAIN WITH 3-HETEROCYCLYL- AND 3-CYCLOALKYL-3-ARYLOXYPROPANAMINES | PHARMACIA & UPJOHN COMPANY (US) | 2004-04-28 | — | — | EP | disclosed |
| US-20030087965-A1 | Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines | PHARMACIA & UPJOHN COMPANY | 2003-05-08 | — | — | US | disclosed |
| US-20030087938-A1 | Treatment of chronic pain with 3-heterocycloxy-and 3-cycloalkyloxy-3-phenylpropanamines | PHARMACIA & UPJOHN COMPANY | 2003-05-08 | — | — | US | disclosed |
| WO-2003011272-A1 | TREATMENT OF CHRONIC PAIN WITH 3-ARYLOXY-3-PHENYLPROPANAMINES | PHARMACIA & UPJOHN COMPANY (US) | 2003-02-13 | — | — | WO | disclosed |
| WO-2003011289-A1 | TREATMENT OF CHRONIC PAIN WITH 3-HETEROCYCLYL- AND 3-CYCLOALKYL-3-ARYLOXYPROPANAMINES | PHARMACIA + UPJOHN COMPANY (US) | 2003-02-13 | — | — | WO | disclosed |
| US-RE31388-E | ORGANOSILANE COATING, BARIUM ALLOY, METAL CAPABLE OF EXOTHERMIC REACTION | SAES GETTERS, S.P.A. (IT) | 1983-09-20 | — | — | US | disclosed |
| US-4139537-A | 3-Aryloxy-1-(2- or 4-iminodihydro-1-pyridyl)-2-propanol antiarrhythmic compounds | COOPER LABORATORIES, INC. (US) | 1979-02-13 | — | — | US | disclosed |
| US-4127361-A | BARIUM ALLOY, ORGANO-SILANE COATING | S.A.E.S. GETTERS S.P.A. (IT) | 1978-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | LIPG 3948/4885TLR8 2695/4885CNR2 915/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | LIPG 3948/4885TLR8 2695/4885CNR2 915/4885 |
| US-20150329544-A1 | CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT | CPNE4, EPB41, AZI2 | LIPG 3208/4885TLR8 4656/4885CNR2 3846/4885 |
| US-20030087965-A1 | Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines | PNMT, OPRL1, OPRK1 | LIPG 4459/4885TLR8 1673/4885CNR2 7/4885 |
| US-20030087938-A1 | Treatment of chronic pain with 3-heterocycloxy-and 3-cycloalkyloxy-3-phenylpropanamines | OPRK1, CNR2, OPRL1 | LIPG 4232/4885TLR8 1627/4885CNR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.